compounded semaglutide enforcement news today New Novo Nordisk initiatives support patient access to authentic, FDA-approved Wegovy® as federal ban on mass compounding of "semaglutide" takes effect compounded semaglutide fda enforcement news

ET: This article was updated with additional information and comments from Heather Williams

Search strategy and study selection We conducted a comprehensive systematic search across five electronic databases: PubMed, Embase, Web of Science, Scopus, and the Cochrane Library, as well as the Google Scholar search engine, from inception to September 30, 2025, to identify studies investigating the association between GLP-1 receptor agonists and AUD outcomes

Tirzepatide, by contrast, showed no significant increase in biliary risk in the available data

The absence of FDA-approved GLP-1 patches also increases the risk for unexpected side effects and adverse reactions